Sonnet Biotherapeutics Holdings Inc. (SONN)
Market Open
2 Dec, 21:00
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
1. 26
-1.84
-59.3548%
$
8.43M Market Cap
- P/E Ratio
- Div Yield
10.43M Volume
-1.23 Eps
$ 3.1
Previous Close Want to track SONN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 0.13 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
SONN Earnings Reports FAQ
What is the earnings per share (EPS) for SONN?
The current EPS is -1.23.
What is the company's earnings growth rate?
Sonnet Biotherapeutics Holdings Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Sonnet Biotherapeutics Holdings Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Sonnet Biotherapeutics Holdings Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for SONN at this time, as Sonnet Biotherapeutics Holdings Inc has no recent EPS data to calculate it.
